NeuroSense Therapeutics NRSN Income Statement (2020-2025)

NASDAQ NRSN
$0.38 +0.03 (+8.16%)
As of: Aug 21, 2026 · 1:42 PM EDT
Income Statement Dec2020 Jun2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Jun2025 Dec2025
Operating items
Research & Development (Quarter) 4.54M4.43M-1.30M4.46M-8.04M-0.71M-1.85M-1.96M-1.56M12.64M-1.88M5.62M-8.35M10.31M
Selling, General & Administrative (Quarter) -0.45M-0.69M-1.97M-1.72M-1.61M0.33M-1.14M-1.41M-1.07M-1.16M-1.11M-1.18M-1.23M-0.69M
Operating Expenses (Quarter) 4.08M3.75M-3.26M2.74M-9.65M-0.38M-2.99M-3.37M-2.63M11.49M-2.99M4.44M-9.57M9.62M
Operating Income (Quarter) -0.95M0.96M-3.26M-3.59M-3.32M-0.38M-2.99M-3.37M-2.63M-3.06M-2.99M-3.03M-2.11M-1.77M
EBIT (Quarter) -0.95M0.96M-3.26M-3.59M-3.32M-0.38M-2.99M-3.37M-2.63M-3.06M-2.99M-3.03M-2.11M-1.77M
Non-operating items
Interest & Investment Income (Quarter) 2.73M0.57M0.14M0.34M0.21M0.06M0.14M3.69M0.34M
Non Operating Income (Quarter) 0.02M-0.02M0.55M0.11M0.33M-0.92M0.07M-0.28M2.28M-0.12M-2.41M2.17M-0.04M-0.03M
Net income details
EBT (Quarter) 5.18M7.16M-2.71M8.91M-15.39M19.68M-2.92M-3.65M-0.35M-3.19M-5.40M11.66M-14.67M18.62M
Profit After Tax (Quarter) 5.18M7.16M-2.71M8.91M-15.39M19.68M-2.92M-3.65M-0.35M-3.19M-5.40M11.66M-14.67M18.62M
Income from Continuing Operations (Quarter) 5.18M7.16M-2.71M8.91M-15.39M19.68M-2.92M-3.65M-0.35M-3.19M-5.40M11.66M-14.67M18.62M
Consolidated Net Income (Quarter) 5.18M7.16M-2.71M8.91M-15.39M19.68M-2.92M-3.65M-0.35M-3.19M-5.40M11.66M-14.67M18.62M
Income towards Parent Company (Quarter) 5.18M7.16M-2.71M8.91M-15.39M19.68M-2.92M-3.65M-0.35M-3.19M-5.40M11.66M-14.67M18.62M
Net Income towards Common Stockholders (Quarter) 5.18M7.16M-2.71M8.91M-15.39M19.68M-2.92M-3.65M-0.35M-3.19M-5.40M11.66M-14.67M18.62M
Additional items
EPS (Basic) (Quarter) 2.741.15-0.430.79-1.361.71-0.00M-0.27-0.03-0.23-0.400.70-0.871.00
EPS (Diluted) (Quarter) 2.741.15-0.250.79-1.351.71-0.25-0.27-0.03-0.23-0.350.70-0.831.00
Shares Outstanding (Quarter) 5.52M1.89M6.24M6.24M11.29M11.29M11.50M0.00M13.62M13.62M13.64M13.64M16.77M16.77M18.60M25.40M25.48M
Shares Outstanding (Diluted) (Quarter) 1.89M6.24M10.99M11.29M11.39M11.50M11.79M13.62M12.46M13.64M15.41M16.77M17.59M18.60M25.40M25.48M
Shares Outstanding (Entity) (Quarter) 137.98M47.18M156.09M282.37M287.61M340.58M0.02M465.05M635.07M637.03M
EBITDA (Quarter) -0.95M0.96M-3.26M-3.59M-3.32M-0.38M-2.99M-3.37M-2.63M-3.06M-2.99M-3.03M-2.11M-1.77M
Interest Expenses (Quarter) 0.01M0.20M-0.02M-0.04M-0.01M0.15M-0.31M-1.89M-0.01M2.66M7.13M0.18M